Drug therapy for improving the renal function after kidney transplantatio
Phase 1
Recruiting
- Conditions
- End-stage renal disease.Chronic kidney disease, stage 5
- Registration Number
- IRCT2017101331487N5
- Lead Sponsor
- Vice-chancellor for Research, Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- end stage renal disease (ESRD) patients
- candidate for renal transplant
- graft from living donor
- age from 18 to 70 years old
Exclusion criteria:
- bradycardia (HR<50)
- hypotension (SBP<100)
- ejection fraction below 30% (EF<30%)
- transplant from cadaver
- simultaneous transplantation of kidney and pancreas
- having contraindication for kidney transplantation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method